APAC Eubiotics Industry Overview
| Study Period: | 2018 - 2028 |
| CAGR: | 5.8 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and it's growth?
APAC Eubiotics Market Analysis
The Asia-Pacific feed probiotics market was valued at USD 885.2 million in 2019 and is projected to witness a CAGR of 7.4% over the forecast period. Development of research programs by local and global players are the major factors that are driving the growth of the market. Provita Eurotech Ltd, Life Products, Inc., Calpis Co. Ltd, Chr. Hansen A/S and Lallemand, Inc. are some of the major players operating in the market. Studies showed that Probiotics have enhanced the growth rate in broilers better than AGP (avilamycin) and other substitutes for AGP, such as phytochemicals, such as essential oils. Thus, increasing awareness pertaining to the nutritional benefits of probiotics is likely to further drive the Eubiotics market during the forecast period.
APAC Eubiotics Industry Segments
Feed Eubiotics are considered to be the commercially-manufactured feed additive products that are used to enhance the characteristics such as weight gain, feed conversion ratio, and feed intake when fed in appropriate proportions. The feed Eubiotics that is accounted for in the commercial compound feed production has only been considered in the scope of the study.
| Type | ||||||
| ||||||
| ||||||
| Organic Acids | ||||||
| Essential Oils |
| Geography | ||||||||||
|
APAC Eubiotics Market Trends
This section covers the major market trends shaping the APAC Eubiotics Market according to our research experts:
Yeast Derived Probiotic Supplemets to Drive the Eubiotics Market Growth
Yeast Probiotic fraction supplements have become a key focus area in improving gut functions at various levels such as intestinal microbiota stabilization, gut integrity improvement, and natural defense modulation. The ongoing field trials also highlighted the positive impact of yeast probiotics on the lactation phase of cattle, and swine alongside evidence of reduced treatment costs in livestock farming. As of March 2020, a field trial was conducted in concern with Bovine Respiratory Disease(BRD). A ban on antibiotics has promoted the alternative methods of research to treat this BRD. At a dosage rate of 5 grams per head per day, a cattle feedlot of 120 in total was treated with Actisaf Sc 47 and Safmannan, a yeast probiotic solution developed by Phileo Lesaffre Animal Care. The trial results signified the improved performance in terms of body weight by 1.5% and recovery from the morbidity and significantly reduced the treatment cost by 53.4%. Another field trial made by Lallemand as of February 2020, mentioned the improved performance of hyper prolific sows when treated with probiotic yeast, S. c. boulardii. Thus, innovating such novel solutions to enhance the cattle performance can be treated as a potential opportunity to find sustainable alternatives for antibiotics to improve animal performance in the years to come.
To understand key trends, Download Sample Report
China to Dominate the Eubiotics Market
China is one of the major players in the global feed probiotics industry, contributing around 50.80% revenue share in the Asia-Pacific probiotics market. The production of Eubiotics, especially probiotics for the aquaculture industry is a thriving sector in China. Lactobacillus is the most common variant of probiotic bacteria used in the aquafeed industry in China. Owing to the African Swine Fever (ASF) outbreaks in China, the pig herds reduced significantly in 2018. Slow herd replenishment, especially in the swine fever affected regions, is contributing to the near time shortfall and resulting in a decrease in swine feed in China. The aforementioned trends vividly claim that the probiotics industry in China to be profoundly characterized by strong R&D investments focusing on product and regional expansion. Moreover, the increasing regulations, for instance, strict norms by the EU Commission and Food and Drug Administration(FDA), pertaining to the use of antibiotics in the feed industry is likely to further boost the feed Eubiotics market, over the forecast period in China.
To understand geography trends, Download Sample Report
APAC Eubiotics Market Competitor Analysis
The market studied is highly fragmented and is dominated by Chr. Hansen A/S, DuPont de Nemours Inc., Koninklijke DSM NV, and Bluestar Adisseo Company. DuPont de Nemours Inc. and Chr. Hansen A/S, being the market leaders, cater to a wider range of product offerings and have a strong geographical presence, providing a competitive advantage in the market. The continuous growth in the revenue generation is further assisting the market's growth. The market leaders, such as Chr. Hansen, are offering a wider range of feed probiotics, including BIOPLUS® YC, GALLIPRO®, GALLIPRO® Tect, and BOVAMINE® Dairy, catering to a surplus range of animals, including the swine, poultry, and dairy industries. Moreover, the company accounted for 22% of the share of the Health and Nutrition sector in 2018.
APAC Eubiotics Market Top Players
DSM Nutritional Products, Inc.
Novus International, Inc.
Kemin Industries
Bluestar Adisseo Company
Lallemand, Inc.
*Disclaimer: Major Players sorted in no particular order
APAC Eubiotics Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions & Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.3 Market Restraints
-
4.4 Porter's Five Forces Analysis
-
4.4.1 Bargaining Powers of Buyers
-
4.4.2 Bargaining Powers of Suppliers
-
4.4.3 Threat of New Entrants
-
4.4.4 Threat of Substitutes
-
4.4.5 Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 Type
-
5.1.1 Probiotics
-
5.1.1.1 Lactobacilli
-
5.1.1.2 Bifidobacteria
-
5.1.1.3 Other Probiotics
-
-
5.1.2 Prebiotics
-
5.1.2.1 Inulin
-
5.1.2.2 Fructo-Oligosaccharides
-
5.1.2.3 Galacto-Oligosaccharides
-
5.1.2.4 Other Prebiotics
-
-
5.1.3 Organic Acids
-
5.1.4 Essential Oils
-
-
5.2 Geography
-
5.2.1 Asia-Pacific
-
5.2.1.1 China
-
5.2.1.2 India
-
5.2.1.3 Indonesia
-
5.2.1.4 Thailand
-
5.2.1.5 Japan
-
5.2.1.6 South Korea
-
5.2.1.7 Australia
-
5.2.1.8 Rest of Asia-Pacific
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Most Adopted Strategies
-
6.2 Market Share Analysis
-
6.3 Company Profiles
-
6.3.1 Life Products, Inc
-
6.3.2 Calpis Co. Ltd
-
6.3.3 Chr. Hansen A/S
-
6.3.4 Lallemand, Inc.
-
6.3.5 Danisco A/S
-
6.3.6 DSM Nutritional Products, Inc.
-
6.3.7 Orffa International Holding B.V.
-
6.3.8 Novus International, Inc.
-
6.3.9 Kemin Industries, Inc.
-
6.3.10 Biovet Joint Stock Company
-
6.3.11 Biomin Holding GmbH
-
6.3.12 Bluestar Adisseo Company
-
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
-
8. IMPACT OF COVID-19
APAC Eubiotics Market Research FAQs
What is the study period of this market?
The Asia Pacific Eubiotics Market is studied from 2018 - 2028.
What is the growth rate of Asia Pacific Eubiotics Market?
The Asia Pacific Eubiotics Market is growing at a CAGR of 5.8% over the next 5 years.
Who are the key players in Asia Pacific Eubiotics Market?
DSM Nutritional Products, Inc., Novus International, Inc., Kemin Industries, Bluestar Adisseo Company, Lallemand, Inc. are the major companies operating in Asia Pacific Eubiotics Market.
Asia Pacific Eubiotics Industry Report
In-depth industry statistics and market share insights of the Asia Pacific Eubiotics Market sector for 2020, 2021, and 2022. The Asia Pacific Eubiotics Market research report provides a comprehensive outlook of the market size and an industry growth forecast for 2023 to 2028. Available to download is a free sample file of the Asia Pacific Eubiotics Market report PDF.
